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Abstract 
 
Background/Aim. Obesity is an established risk factor for 
numerous chronic diseases. The aim of this study was to in-
vestigate the effect of well-balanced different caloric restric-
tion (CR) diets on anthropometric parameters and standard 
biochemical cardiovascular risk markers [lipid profile, glucose 
homeostasis and high sensitivity C-reactive protein (hs-CRP)] 
in overweight/obese females. Methods. Participants (age 20–
40 years) were randomized into 3 different CR diet groups: 
the group I – restriction of 20% calories from baseline energy 
requirements, the group II – restriction of 50% calories from 
baseline energy requirements and the group III – alternating 
daily diets with 70%/30% restriction. The study lasted 42 
weeks. Anthropometric parameters were measured at the 
start and after 4, 8, 20 and 42 weeks after dietary intervention 
beginning. Biochemical markers were determined at baseline 
and after 20 and 42 weeks from dietary restriction start.  
Results. Body weight, body mass index (BMI), waist circum-
ference (WC) and body fat (in %), in the different CR diet 
groups significantly decreased after 42 weeks. Body weight 
was less 11 kg in the group I and 12 kg in the groups II and 
III. WC was reduced by 11 cm in the groups I and III and by 
10 cm in the group II. Different CR diets had the same ef-
fects on body fat (a reduction of 15% of body fat). Total cho-
lesterol decreased by 7% in the group I and by 8% in the 
group III. Low density lipoprotein (LDL) cholesterol de-
creased by 14% in the group I and by 13% in group III. 
There were no significant changes in total and LDL-
cholesterol levels in the group II. The atherogenic index pre-
sented as trigliceride/high density lipoprotein (TG/HDL) ra-
tio decreased by 0.22 in the group I, by 0.25 in the group II 
and by 0.32 in the group III. Various CR diets had the same 
effects on reducing the hs-CRP levels. Conclusion. Different 
CR diets with the same macronutrient content are equally ef-
fective in reducing body weight, WC and body fat, improve 
cardiometabolic risk factors and decrease level of pro-
inflammatory hs-CRP in overweight/obese females. 
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Apstrakt 
 
Uvod/Cilj. Gojaznost je faktor rizika od nastanka mnogih 
hroničnih bolesti. Cilj istraživanja bio je da se ispita efekat 
dobro izbalansirane ishrane različitih kalorijskih ograničenja 
na antropometrijske parametare i standardne biohemijske 
kardiovaskularne markere rizika [(lipidni profil, homeostazu 
glukoze, visoko senzitivni C-reaktivni protein – high-
sensitivity C-reactive protein (hs-CRP)] kod predgojaz-
nih/gojaznih žena. Metode. Ukupno 97 žena, između 20 i 
40 godina starosti, konzumirale su uravno-težene, kalorijski 
različite-restriktivne dijete, na sledeći način: I grupa (n = 37) 
– ograničenje 20% kalorija od osnovnih energetskih potre-
ba; II grupa (n = 30) – ograničenje od 50% kalorija od os-
novnih energetskih potreba i III grupa (n = 30) – naizmeni-
čna dnevna restrikcija od 70% i 30% kalorija od osnovnih 
energetskih potreba. Stepen uhranjenosti je određivan an-
tropometrijskim merenjima na početku i nakon 4, 8, 20 i 42 
nedelje od uvođenja dijeta. Biohemijski markeri analizirani 
su na početku i nakon 4, 8, 20 i 42 nedelje. Rezultati. Kalo-
rijski različite restriktivne dijete dovele su do značajnog 
smanjena telesne mase, indeksa telesne mase (body mass index 
– BMI), obima stuka (OS) i % telesne masti nakon tretmana 
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od 42 nedelje. Telesna masa snižena je za 11 kg u grupi I, a 
za 12 kg u grupama II i III. Za 11 cm je smanjen OS u gru-
pama I i III i za 10 cm u grupi II. Gubitak  15% ukupne te-
lesne masti ostvaren je za sve vrste dijeta nezavisno od razli-
čitog kalorijskog unosa. Koncentracija ukupnog i (low density 
lipoprotein) holesterola (LDL-holesterola) snižena je za 7% i 
14% u grupi I i za 8% i 13% u grupi III. Dijeta sa 
redukcijom kalorijskog unosa od 50% nije imala efekta na 
nivo ukupnog i lipoprotein niske gustine LDL-holesterola. 
Aterogeni indeks predstavljen kao odnos trigliceridi/lipo-
protein visoke gustine (high density lipoprotein) – TG/HDL 
bio je manji za 0,22 u grupi I, za 0,25 u grupi II i za 0,32 u 
grupi III. Kalorijski različite restriktivne dijete dovele su do 
istog sniženja nivoa hs-CRP. Zaključak. Restriktivne vrste 
dijeta sa različitim kalorijskim unosom i sa istim procentom 
zastupljenosti makronutrijenata jednako su efikasne u sma-
njenju telesne mase, OS i % telesne masti, dovode do pobolj-
šanja faktora kardiometaboličkog rizika i smanjenja pro-
inflamatornog hs-CRP kod predgojaznih/gojaznih žena. 
 
Ključne reči: 
dijeta, redukciona; antropometrija; gojaznost; žene; 
lipoproteini; glukoza; c-reaktivni protein; telesna masa, 
indeks. 
 
Introduction 
Increasing obesity is declared as a huge public health 
problem in the world. Some of chronic diseases are closely 
related to the existing obesity. These are atherosclerosis, 
hypertension, hyperlipidemia, insulin resistance 
syndrome 1, 2, musculoskeletal diseases, polycystic ovary 
syndrome, some types of cancer and lack of a sense of 
psychological well-being. Serbia has a growing population of 
overweight people in the last ten years, too 3.  In fact, about 
35% of adult population are overweight and 21% considered 
obese 4. Metabolic risk factors are closely related to nutrition 
status and body composition. Inflammation and 
cardiovascular diseases are result of obesity 1, 5. 
Waist circumference (WC) is most commonly used as 
an indicator of abdominal adiposity 6. Obesity with a 
combination of abdominal obesity is related to metabolic 
disorders such as dyslipidemia and hyperinsulinemia, 
disrupted homeostasis and inflammation 2, 5. Nutritional 
therapy is a sovereign method in achieving weight loss. 7 
Calorie restrictive (CR) diets with energy limitation and 
balanced macronutrient composition are most often 
applied 8, 9. The success in achieving weight loss is 
determined with degree of calorie restriction. 
Calorie restrictive diets consist of reducing energy 
intake by 15–60% of common daily energy requirements. 
Obesity treatment guidelines issued by the National Institute 
of Health considered a good reduction in caloric intake by 
500 kcal/day in the treatment of overweight and the class I 
obesity. This level of CR diet is recommended to people with 
diagnosed more than one risk factor, too 10. 
Low-calorie diets (LCDs) are high in carbohydrate (55–
60%) and low in fat (less than 30% of caloric intake). Also, 
LCDs have a low glycemic index, but a high fiber content. 
There is a solid evidence that indicates that LCDs  during a 
period of 3–12 months, can lower total body weight by an 
average of 8% 10, 11. Thus, it is implicated that CR may be 
critical factor in determining the results of intervention. 
Different dietary interventions with weight loss, 
decrease of abdominal obesity, an achievement of desirable 
values of serum cholesterol, triglycerides and fasting insulin 
concentrations glucose tolerance and blood pressure as a goal 
have been set in the last decades 12–14. 
To our knowledge, the number of studies that have 
examined the influence of different dietary intervention on 
enhancing weight loss and reducing cardiometabolic risk 
factors including blood lipids profile, glucose homeostasis 
and inflammation  are limited. Therefore, the aim of this 
study was to investigate the long-term effects of well-
balanced diet with different CR on anthropometric 
parameters, body fat mass and standard biochemical 
cardiovascular risk markers, e.g., lipid profile, parameters of 
glycoregulation and  high-sensitive C-reactive protein (hs-
CRP) in overweight and obese females. 
Methods 
Participants 
We designed a follow-up, prospective, intervention 
study in the routine management of 240 overweight or obese 
females that attended the Department of Nutrition, Institute 
of Hygiene, Military Medical Academy (MMA) and were 
initially enrolled from January 2014 to May 2015. Due to the 
high drop-off rate, 97 females with baseline body mass index 
(BMI) ≥ 25 kg/m2, completed the study. 
Key inclusion criteria were: female gender, age 20–40 
years, BMI between 25 and 44.9 kg/m2, stable weight (± 2 
kg) and sedentary or lightly active status for 3 months before 
beginning of the intervention, with normal fasting glucose 
levels. Subjects that had history of cardiovascular disease, 
liver or kidney dysfunction or cancer, taking weight loss, 
lipid-lowering, or glucose-lowering medications were 
excluded. The study was approved by the Human Research 
Ethics Committee of the MMA. Written consent was signed 
by all study participants at the start of the study. 
Study design 
Participants were matched for age and BMI, and then 
were randomly selected using computer-generated random 
number allocation for consumption of different well-
balanced caloric restriction diets during 42 weeks. 
Participants were selected into one of three groups: 
the group I (n = 37) – restriction of 20% calories from ba-
seline energy requirements; the group II (n = 30) –  50% 
CR from baseline energy requirements and the group III (n 
= 30) –  70%/30% CR alternating daily diets (one day 70% 
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and the following day 30% caloric restriction, respectively 
from baseline energy requirements). Participants in the CR 
groups were educated by our medical dietitian on principles 
to reduce their daily energy intake in order to achieve 
weight reduction. 
After careful consideration of global nutrition, a 
personalized CR diet (700–1700 kcal/day) was prescribed, 
aiming at the achievement of a moderate weight loss. These 
low and moderate calories diets are based on conventional-
type of intervention. In general, diets are low in energy and 
fat caloric intake with high carbohydrate and fibre content, 
based on an increased intake of whole grain cereals, 
vegetables and fruit 10.  Proposed food plan included 
carbohydrates (55–60% of total calories with 14 g dietary 
fibre/1,000 kcal), proteins (15–20% of total calories with 
1.0 g/kg body weight/day), dietary cholesterol lower than 
300 mg/day and limit of fat intake to < 30 % of total 
calories (with limit of saturated fatty acid to < 10 % of total 
calories intake) mostly mono and polyunsaturated fats. 10, 11 
The CR diets were also balanced in terms of micronutrients 
intake (vitamins and minerals in the recommended diet 
must always be checked). On a very LCDs, weight losses 
for women have been reported to be 1.5–2 kg/week with 
the average weight loss of 20 kg during 12 weeks. Low-
energy diet for 20–24 weeks, lead to reduce of 0.4–0.5 
kg/week with the average weight loss of 8.5 kg. 15 There 
was no special physical activity prescribed during the 
study. Individuals met with our medical dietician at 
baseline, and after 4 and 8 weeks and later were followed 
monthly. The initial weight-loss goal was expected to be 
10% over during 10-month dietary treatment period. 
Anthropometric parameters 
Anthropometric parameters were measurement at 
baseline and after 4, 8, 20 and 42 weeks in three different 
CR groups.  A qualified nutritionist conducted 
anthropometric measurements. Body weight and height 
were measured and BMI was calculated. The height and 
weight of the participants dressed in light clothing without 
shoes were determined.  Standard measurements of body 
height were performed. Obesity was classified, according 
to the World Health Organization (WHO) guidelines. 5, 10 
Percentage of body fat was calculated from thickness of 
skinfolds on 4 measured points 16. After measurements of 
WC subjects were classified into 3 groups according to 
health risk 17. Anthropometric measurements were taken by one 
person. 
Biochemical analyses 
At baseline, after 20 weeks and at the end of dietary 
treatment (week 42), fasting blood samples were collected 
from all participants. The serum concentration of glucose, 
hemoglobin glucosylated test (HbA1C), triacylglycerols 
(TG), total cholesterol (TC), high-density lipoprotein (HDL)-
cholesterol and hs-CRP were measured using enzymatic kits 
(Roche Diagnostics, Basel, Switzerland) on a Siemens 
autoanalyser (Dimension®, RxL Max, Siemens Dade Be-
hring). Calculations mde were: low-density lipoprotein 
(LDL) cholesterol via the Friedewald formula, 18 and athero-
genic index as TG/HDL cholesterol ratio. We established a 
cut-off value of 5% at 6 months to indicate the efficacy of 
treatment. 
Statistical analysis 
Anthropometric parameters and concentrations were 
presented as mean values ± standard deviation (SD) and 
statistically analyzed by SPSS 20 software (IBM, Armonk, 
NY, USA). Since all variables showed normal distribution, 
checked by Shapiro Wilk test, univariate analysis of variance 
(ANOVA) was performed to assess differences in baseline 
characteristics and dietary data among CR groups. The effect 
of a diet duration (time 0–42 weeks) and the diet itself 
(different CR treatments) on continuous variables was 
determined using repeated ANOVA (taking time as within-
subject factor and a diet as between-subject factor) to assess 
differences among different CR diet groups during the study 
(effect: time x CR group). Post hoc analyses were applied with 
Bonferroni adjustments for multiple parameters comparisons. 
Differences among groups were assessed by repeated 
ANOVA, followed by Tukey post hoc test. P values < 0.05 
indicated statistical significance. 
Results 
Two hundred and forty subject were assessed at the be-
gining of the study (week 0) and 97 subject (the group I – 
20% CR, n = 37, the group II – 50% CR, n = 30, the group 
III – 70/30% CR, n = 30), who represent approximately 40% 
of the participants from the beginning of the study, comple-
ted dietary interventions after 42 weeks. At the beginning , 
various CR diet groups were similar in most parameters that 
were monitored, except WC, serum fasting glucose and hs-
CRP levels, which were significantly lower in the group III 
with 70%/30% alternating daily CR compared to baseline le-
vels in the group I – 20% CR and the group II – 50% CR 
(Table 1). 
During the study period of 42 weeks, different CR 
groups had similar reductions in body weight, percentage 
of body fat and WC (time 0–42 weeks: p < 0.001; effect: 
time x CR diet group; p > 0.05) (Table 1). All CR-diet 
groups achieved a weight loss of 5% of their initial body 
weight after 4 weeks of the treatment. Waist circumferen-
ce decreased (p < 0.001) by 11 cm in the group I (20% 
CR) and by 12 cm in the group II (50% CR) and the group 
III (70%/30%) from initial values during weight loss peri-
od, despite that WC was low at baseline in the group III 
(70%/30%) compared to other two CR groups. Different 
caloric restriction diets had the same reduction of 15% of 
total body fat compared to baseline (different treatments p 
= 0.432, time 0–42 weeks: p < 0.001). Table 1 shows that 
during treatment period, BMI in different CR diet groups
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decreased significantly by 3.95 kg/m2 in the group I (20% 
CR), by 4.44 kg/m2 in the group II (50% CR), and by 4.79 
kg/m2 in the group III (70%/30% CR). After 42 weeks, total 
cholesterol decreased by 7% (change -0.35 mmol/L) in the 
group I (20% CR) and by 8% (change – 0.43 mmol/L) in the 
group III (70%/30% CR) compared to baseline. LDL-
cholesterol decreased by 14% (change -0.47 mmol/L) in the 
group I (20% CR) and by 13% (change -0.42 mmol/L) in the 
group III (70%/30% CR) compared to the baseline levels 
(Table 2). There was no significant changes in the total and 
LDL-cholesterol serum levels during the study period in the 
group II (50% CR). However, after 42 weeks the serum 
HDL-cholesterol level decreased significantly (p < 0.049) 
only in the group I (20% CR) while the 70%/30% CR diet 
had no effects on serum HDL-cholesterol levels in our study 
participants. Atherogenic index presented as TG/HDL ratio 
was significantly decreased by 0.22 ± 0.23 in the group I 
(20% CR), by 0.22 ± 0.29 in the group II (50% CR), and by 
0.32 ± 0.28 in the group III (70%/30% CR). 
Table 2 shows that after 42 weeks the level of the serum 
HDL-cholesterol increased significantly by 0.07 mmol/L, se-
rum triglycerides levels decreased by 0.25 mmol/L, total and 
LDL-cholesterol decreased by 0.35 mmol/L and 0.47 
mmol/L respectively, plasma levels of fasting glucose decre-
ased by 0.12 mmol/L, concentration of HbA1C decreased by 
0.25% and hs-CRP levels decreased by 2.22 mg/L in the mo-
derate caloric restriction diet group (the group I). Repeated 
ANOVA showed significant differences in the serum total 
and LDL-cholesterol levels from baseline to the end of the 
study when compared treatment effect among CR groups (ef-
fect: time x CR group: p < 0.025 and p < 0.024, 
respectively). The diet with 20% energy deficit had no signi-
ficant effect on total and LDL-cholesterol levels in the serum 
but only in this diet group fasting glucose levels decreased 
significantly (different treatment: p < 0.012). Also, this diet 
group had the greatest reduction in HbA1C by 0.45% consi-
dering the baseline levels, compared to other two CR groups 
according to the treatment duration (time  0–42 weeks:  
p < 0.001). The highest decrease in triglycerides (0.38 
mmol/L) and smaller reduction in levels of fasting glucose 
(0.09 mmol/L) was in the diet group III with 70%/30% alter-
nating daily CR. HDL-cholesterol concentration in this diet 
group, firstly decreased during 20 weeks and returned at ba-
seline levels at the end of the study (different treatment: 
p = 0.049). However, after 42 weeks, hs-CRP decreased by 
36% and 38% in the group I and the group II (time 0–42 
weeks: p = 0.001), and by 48% in the group III compared to 
baseline values, despite that hs-CRP in the group III was 
statistically lower than in other groups at baseline (different 
treatment: p = 0.048). 
Discussion 
Our dietary intervention demonstrated that overweight 
and obese female, consuming different CR diets had the si-
milar body weight reduction by 5% after 4 weeks of the trea-
tment and improved cardiometabolic risk factors. Generally, 
different CR diet groups achieved 12% (~11 kg) weight loss 
at 42 weeks of the treatment from initial body weight. When 
we analyzed WC and percentage of body fat as outcome va-
riables, there were no differences in the effectiveness among 
the different CR weight-loss methods. Participants in diffe-
rent CR (20%, 50%, 70%/30%) groups during long-term pro-
tocol (42 weeks) with overall weight lost by 12%, had simi-
lar reduction in WC (11–12cm) and % of body fat (15–16%). 
These findings indicate that different CR diets have the same 
effect in reducing body weight and fat mass in overweight 
and obese women. Our results are consistent with the evi-
dence that most short-term dietary interventions (8–24 
weeks) produce body weight decreases of 3–10%, while lon-
ger-term protocols (25–52 weeks) produce weight reductions 
of 10–15% 6–8, 12–14, 19–20. 
It is well known that dietary interventions are effective 
for weight loss 7, 21. In overweight subjects when BMI is 25–
29.9 kg/m2, advice is to introduce CR, physical activity and 
lifestyle modification. Tokunaga and Furubayashi 22 sugges-
ted that the diets containing 1000–1200 kcal/day should be 
selected for obese patients. There was some evidence that 
CR diets lead to clinically significant weight loss regardless 
of which macronutrients stand out 23.  In this research, our 
participants had different CR diets (20%, 50% and 70%/30% 
CR), but with the same macronutrient content: carbohydrate 
(55–60% of total calories) proteins (15–20% of total calori-
es) and fat (less than 30% of energy intake). Very LCDs with 
600 kcal/day should not be used routinely for weight-loss 
therapy because it requires special monitoring and supple-
mentation. So, in the diet group III we combined alternating 
daily CR; on the first day very LCD of 70% and on the se-
cond day moderate LCD with 30% CR of baseline energy 
requirements. 
No dose-response link between greater degree of CR and 
larger amounts of weight loss was presented in scientific 
works. For example, 6% reduction from baseline values during 
12–13 weeks of the procedure was shown with 16% and 23% 
CR diets 24, 25. Our results are consistent with the statement that 
a degree of CR is not a crucial factor which affects the outco-
me of weight loss. There was some evidence that short-term 
diet (4–12 weeks)  made significant reductions in body fat of 
10–20%. Moderate-term trials (13–24 weeks) showed similar 
result, 11–34% in reduction of body fat from baseline 24–28. 
Visceral obesity is closely related with greater risk of 
cardiovascular disease (CVD) and type 2 diabetes 29, 30. For 
example, in the studies with 6–8% weight loss visceral fat 
mass was reduced by 6–13% from baseline 6, 30. In our study 
with 12% weight loss (~11kg), WC was reduced by 11 cm 
(15% from baseline). These changes are important since WC 
is an important predictor for cardiometabolic risk and meta-
bolic syndrome 6, 17. 
Reductions in body weight are generally accompanied 
by favorable changes in metabolic disease risk parameters. It 
has been presented that loss of 5%–10% of the initial body 
weight is a sufficient to perform clinically evident improve-
ment of the metabolic profile of obese persons 30–33. Publis-
hed studies suggest that, for instance, weight loss of 5–15% 
results in fairly consistent decreases in the serum of 
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total cholesterol (5–20%), LDL cholesterol (5–20%), fasting 
glucose (5–10%), and insulin (10–40%) levels 6–9, 12–14, 16, 17, 19. 
In our study, reductions in cardiometabolic risk factors 
were noticed in all CR diet groups. Less decrease of 
triglycerides levels (23%) was in the diet group I (20% CR) 
compared with another two groups, the group II (50% CR) 
and the group III (70%/30% CR) (28% and 31%, 
respectively). In our study, 50% CR intake had no effect on 
total and LDL-cholesterol serum levels in overweight and 
obese females regardless of the decrease of 12% in body 
weight. There was some evidence that plasma lipid concen-
trations (total cholesterol, LDL cholesterol and TG) had a 
tendency to decline after loss of 5% of body weight 34–36. 
Previous studies in overweight and obese patients with di-
abetes type 2, indicated that modest weight loss of 5–10% from 
initial body weight markedly improve glycemic control and 
CVD risk factors after one year 37, 38. In our study in overweight 
and obese non diabetic females with 12% reductions of initial 
weight during 42 weeks, different CR diet decreased fasting 
glucose levels (2–10%) and  HbA1c (5–8%) from baseline le-
vels with greater reduction in glucose levels (10%) in the group 
I (moderate 20% CR diet), although, HbA1c% had better res-
ponse with 50% CR (the group II) (change – 0.45 ± 0.82%) 
compared to the 20% CR diet group (change – 0.25 ± 0.89%). 
This is a worse response in non-diabetic obese or overweight 
females compared to evidence that in overweight or obese sub-
jects with diabetes type 2 HbA1c has a tendency to decline 
(0.4%) after body weight loss of 5% 39. Participants in the group 
III with combined alternating daily 70%/30% CR diet had low 
response to glucose levels reduction (only 2%). 
However, no statistically significantly different changes 
in triglyceride and HDL-cholesterol concentrations, glucose 
levels and HbA1c and TG/HDL ratio among different CR diet 
groups were observed following long-term protocols of 42 
weeks in our study. Interestingly, data from the Diet, 
Obesity, and Genes (DiOGenes) Study, first demonstrated 
that LCDs induced 8% weight loss in obese adults during 
treatment period of 8 weeks. Besides, this study showed that 
consuming one of the four diets with no caloric restriction, 
different in protein content or food glycemic index during 26 
weeks, had similar effects on the serum lipid status and fas-
ting glucose levels 39. Some studies have shown that macro-
nutrient composition of CR can change the blood lipid profi-
le response to weight loss 40–42. Recent papers have suggested 
that atherogenic index (TG/HDL-cholesterol ratio) is most 
useful for the discrimination of insulin resistance in indivi-
duals 43–45. Our study showed that 12% reduction in body 
composition can induce decline (28–35%) in this biomarker 
of the disease risk in overweight and obese females. 
CRP is an sensitive inflammatory marker 45, 46, whose va-
lues fall in the blood after loss of 10% of initial body weight 47. 
Marked weight loss has also been found to reduce the concen-
tration of hs-CRP 48, 49.  Significant reduction in body weight 
decreases the concentration of hs-CRP. In our study, 12% re-
duction in body weight produced potent reduction (35–48%) 
in hs-CRP levels. In a recent meta-analysis of 33 weight loss 
intervention studies, conclusion was that there was a strong 
correlation between declines in body weight and the hs–CRP 
levels. Also, this study supported possibility to reduce the hs–
CRP levels by non-pharmacological method such as an 
ordinary weight reduction 50. It is interesting that despite lower 
basal levels of hs-CRP in the diet group III compared to anot-
her two CR diet groups alternating daily CR of 70% and 30% 
showed higher reduction of hs-CRP (48% from baseline) 
compared with 20% and 50% CR diets. These effects are es-
sential for reduction in the CVD risk because hs-CRP is CVD 
predictor and an inflammatory molecule accumulated in the 
atherosclerotic process 46. DiOGenes study showed that hs–
CRP could be, even more reduced by a diet with a low 
glycemic index and significantly less content of proteins 41. 
This study has limitation because we did not divide our 
study population into two subgroups (overweight and obese 
women) and compare the effects of different CR diets between 
them. The reason for this is high dropout rate (60%) that may 
limit the use of the study results in public health programs.  
Conclusion 
Different caloric restriction diets with the same macro-
nutrient content have the same effect in decreasing body 
weight and body fat, as well as similar effect in reduction of 
cardiometabolic risk factors in overweight and obese fema-
les. In addition, this study confirmed that reduced body 
weight have beneficial effect on reducing level of pro-
inflamatory hs-CRP. 
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